Anzeige
Mehr »
Dienstag, 14.04.2026 - Börsentäglich über 12.000 News
Unter dem Radar, voll finanziert: Beginnt jetzt der nächste Gold-Run?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoRed White & Bloom subsidiary wins Ayurcann asset bid
MoRevolution Medicines plans $1 billion dual offering
MoGevo appoints Joan Cetera as VP of communications
MoWilliam Blair reiterates Ocular Therapeutix stock rating on trial data
MoMizuho raises Spyre stock price target to $84 on trial data
MoMizuho raises Ideaya Biosciences stock price target on trial data
MoFreedom Broker cuts Beam Global stock price target on cash concerns
MoMizuho cuts CommVault stock price target on valuation concerns
MoOppenheimer raises Ideaya Biosciences price target on trial data
MoFreedom Broker raises Aehr Test Systems stock price target to $61 on strong bookings
MoLeerink reiterates Eli Lilly stock rating on positive trial data
MoSyre Therapeutics stock price target raised to $106 by Leerink
MoArrow Electronics, Avnet rallied 9% as analyst upgrades on improving sentiment
MoEvercore ISI reiterates Netflix stock rating ahead of earnings
MoTruist raises Ideaya Biosciences stock price target on trial data
MoWarner Music Group invests in Latin music distributor TuStreams
MoSeer receives $2.25 per share buyout proposal from investor group
MoGoldman Sachs raises Ideaya Biosciences stock price target on trial data
MoRaymond James reiterates Strong Buy on Somnigroup stock after Leggett deal
MoJefferies raises Spyre stock price target to $85 on trial data
MoNike faces HSBC downgrade as sports apparel sector faces modest growth
MoLVMH Q1 2026 slides: organic growth holds amid currency headwinds
MoHSBC launches blockchain-based deposit service in U.S.
MoBTIG reiterates Buy on vTv Therapeutics stock, keeps $49 target
MoHeartflow stock rating reiterated at Buy by Canaccord on IP suit